Related Experiment Video
Updated: Jun 15, 2026
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Introducing high dose steroid therapy for MS relapses into the community
Barbara Cassia1, Melanie Ranford-Mills
1Community Intervention Team, South Staffordshire PCT. barbara.cassia@nhs.net
British Journal of Community Nursing
|March 11, 2010
Summary
South Staffordshire Primary Care Trust (PCT) developed a home-based high-dose steroid therapy service for multiple sclerosis (MS) relapses. This initiative, supported by the Queen's Nursing Institute (QNI), aims to prevent crises and enhance community care.
Area of Science:
- Community Nursing
- Neurology
- Healthcare Management
Background:
- Increasing specialist nurses and intermediate care services in South Staffordshire.
- Existing Community Intervention Team (CIT) provides home-based intravenous therapies.
- Collaboration between MS Clinical Nurse Specialist (CNS) and CIT identified a need for proactive relapse management.
Purpose of the Study:
- To establish a community-based service for home administration of high-dose steroid therapy for multiple sclerosis (MS) relapses.
- To leverage existing PCT resources and QNI funding to support the new service.
- To explore strategies for preventing MS-related crises through enhanced community care.
Main Methods:
- Utilized an award from the Queen's Nursing Institute (QNI).
- Integrated high-dose steroid therapy into existing community-based services.
- Collaborated between MS CNS and Community Intervention Team (CIT).
Main Results:
- Successfully established a community-based service for home administration of high-dose steroids.
- Enabled MS patients to receive relapse treatment at home, reducing hospitalizations.
- Demonstrated effective use of existing PCT resources for specialized care.
Conclusions:
- Home-based high-dose steroid therapy is a viable and effective option for MS relapses.
- Interdisciplinary collaboration can enhance proactive management of chronic neurological conditions.
- Community-based services can improve patient outcomes and resource utilization within PCTs.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...